Waters Corporation $WAT Shares Sold by ASR Vermogensbeheer N.V.

ASR Vermogensbeheer N.V. trimmed its position in Waters Corporation (NYSE:WAT) by 0.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,588 shares of the medical instruments supplier’s stock after selling 66 shares during the period. ASR Vermogensbeheer N.V.’s holdings in Waters were worth $5,441,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in WAT. Brighton Jones LLC boosted its stake in Waters by 112.9% during the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after buying an additional 673 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Waters by 15.9% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,318 shares of the medical instruments supplier’s stock valued at $1,602,000 after acquiring an additional 593 shares during the last quarter. Curat Global LLC bought a new position in shares of Waters during the 1st quarter valued at about $80,000. Procyon Advisors LLC grew its stake in shares of Waters by 19.6% in the 1st quarter. Procyon Advisors LLC now owns 1,189 shares of the medical instruments supplier’s stock worth $438,000 after purchasing an additional 195 shares during the last quarter. Finally, Fenimore Asset Management Inc raised its holdings in shares of Waters by 0.4% in the 1st quarter. Fenimore Asset Management Inc now owns 234,488 shares of the medical instruments supplier’s stock worth $86,425,000 after purchasing an additional 1,011 shares in the last quarter. 94.01% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Wall Street Zen cut shares of Waters from a “buy” rating to a “hold” rating in a report on Saturday, July 26th. Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research note on Saturday, September 27th. Robert W. Baird cut their target price on Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 16th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Waters and gave the company a “hold” rating in a research report on Tuesday, August 5th. Finally, Bank of America boosted their price objective on Waters from $370.00 to $375.00 and gave the stock a “neutral” rating in a report on Thursday, June 26th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, Waters currently has an average rating of “Hold” and a consensus target price of $380.43.

Waters Price Performance

WAT opened at $328.95 on Friday. The stock has a fifty day moving average price of $296.92 and a 200 day moving average price of $325.60. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56. The stock has a market cap of $19.58 billion, a price-to-earnings ratio of 29.66, a PEG ratio of 3.00 and a beta of 1.04.

Waters (NYSE:WAT) last issued its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.93 by $0.02. The company had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business’s revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.63 EPS. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Analysts forecast that Waters Corporation will post 12.86 EPS for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.